Compound ID | 1698
Class: Papulacandin
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Active against B. subtilis, Xanthomonas oryzae and Proteus vulgaris |
| Institute where first reported: | Kitasato University, Japan |
| Year first mentioned: | 2018 |
| Highest developmental phase: | Preclinical |
| External links: | |
| Citation: | https://www.nature.com/articles/s41429-018-0102-7 |